← back to search

Jingjing Wu

Fujian Medical University ·
Area of research
Immunology · Pathology and Forensic Medicine
Research interest
Research interests include Galectins and Cancer Biology, Phagocytosis and Immune Regulation, Cancer Mechanisms and Therapy, and Nanoparticle-Based Drug Delivery.
h-index
5
citations
342
works
17
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

LncRNA FOXD2-AS1 promotes the growth, invasion and migration of OSCC cells by regulating the MiR-185–5p/PLOD1/Akt/mTOR pathway
Cancer Genetics 2024cited by 29position: middledoi
LncRNA FOXD2-AS1 Promotes the Growth, Invasion and Migration of OSCC Cells by Regulating the MiR-185-5p/PLOD1/Akt/mTOR Pathway
Journal of Biomedical Nanotechnology 2024cited by 3position: middledoi
Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge
Annals of Oncology 2018cited by 238position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Xin Liu · Nanjing University of Chinese Medicine2 papers (2024–2024)Jian Liu · Zhejiang International Studies University2 papers (2024–2024)Jinhong Zhang · BGI Group (China)2 papers (2024–2024)Yong Zhang · Virginia Commonwealth University2 papers (2024–2024)AmirAli Talasaz · Houston Methodist1 papers (2018–2018)Jonathan M. Loree · BC Cancer Agency1 papers (2018–2018)— · 1 papers (2018–2018)Allan Andresson Lima Pereira · Novartis (Switzerland)1 papers (2018–2018)— · 1 papers (2018–2018)Victoria M. Raymond · CancerCare Manitoba1 papers (2018–2018)Lifang Li · Shandong University1 papers (2024–2024)Lifang Li · The First Affiliated Hospital, Sun Yat-sen University1 papers (2024–2024)Michael J. Overman · The University of Texas MD Anderson Cancer Center1 papers (2018–2018)— · 1 papers (2018–2018)John H. Strickler · Cancer Institute (WIA)1 papers (2018–2018)Scott Kopetz · The University of Texas MD Anderson Cancer Center1 papers (2018–2018)— · 1 papers (2018–2018)Benny Johnson · Lockheed Martin (Canada)1 papers (2018–2018)Van K. Morris · The University of Texas MD Anderson Cancer Center1 papers (2018–2018)— · 1 papers (2018–2018)